Method ological factors affecting 6MWD include track length , encouragement , supplemental oxygen and walking aids .
Supplemental oxygen also affects ISWT and ESWT performance .
Responsiveness was moderate to high for all tests , with greater responsiveness to interventions that included exercise training .
The findings of this review demonstrate that the 6MWT , ISWT and ESWT are robust tests of functional exercise capacity in adults with chronic respiratory disease
This systematic review examined the measurement properties of the 6-min walk test ( 6MWT ) , incremental shuttle walk test ( ISWT ) and endurance shuttle walk test ( ESWT ) in adults with chronic respiratory disease .
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
RATIONALE The 6-minute-walk test ( 6MWT ) is a practical and clinical ly meaningful measure of exercise tolerance with favorable performance characteristics in various cardiac and pulmonary diseases . Performance characteristics in patients with idiopathic pulmonary fibrosis ( IPF ) have not been systematic ally evaluated . OBJECTIVES To assess the reliability , validity , and responsiveness of the 6MWT and estimate the minimal clinical ly important difference ( MCID ) in patients with IPF . METHODS The study population included all subjects completing a 6MWT in a clinical trial evaluating interferon gamma-1b ( n = 822 ) .  Six-minute walk distance ( 6MWD )  and other parameters were measured at baseline and at 24-week intervals using a st and ardized protocol . Parametric and distribution-independent correlation coefficients were used to assess the strength of the relationships between 6MWD and measures of pulmonary function , dyspnea , and health-related quality of life . Both distribution-based and anchor-based methods were used to estimate the MCID . MEASUREMENTS AND MAIN RESULTS Comparison of two proximal measures of 6MWD ( mean interval , 24 d ) demonstrated good reliability ( coefficient = 0.83 ; P < 0.001 ) . 6MWD was weakly correlated with measures of physiologic function and health-related quality of life ; however , values were consistently and significantly lower for patients with the poorest functional status , suggesting good construct validity . Importantly , change in 6MWD was highly predictive of mortality ; a 24-week decline of greater than 50 m was associated with a fourfold increase in risk of death at 1 year ( hazard ratio , 4.27 ; 95 % confidence interval , 2.57- 7.10 ; P < 0.001 ) . The estimated MCID was 24 - 45 m. CONCLUSIONS The 6MWT is a reliable , valid , and responsive measure of disease status and a valid endpoint for clinical trials in IPF
Method ological factors affecting 6MWD include track length , encouragement , supplemental oxygen and walking aids .
Supplemental oxygen also affects ISWT and ESWT performance .
Responsiveness was moderate to high for all tests , with greater responsiveness to interventions that included exercise training .
The findings of this review demonstrate that the 6MWT , ISWT and ESWT are robust tests of functional exercise capacity in adults with chronic respiratory disease
This systematic review examined the measurement properties of the 6-min walk test ( 6MWT ) , incremental shuttle walk test ( ISWT ) and endurance shuttle walk test ( ESWT ) in adults with chronic respiratory disease .